Gregory L. Kucera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gregory L. Kucera has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Adam S. Wilson
11 shared publications- Akiko Chiba
Department of Surgery, Duke University Medical Center, Durham, NC
11 shared publications Alana A. Arnone
11 shared publicationsDavid R. Soto-Pantoja
11 shared publications- Edward A. Levine
Section of Surgical Oncology, Department of General Surgery, Wake Forest University, Winston-Salem, NC, USA.
11 shared publications Hariom Yadav
11 shared publications
Latest Publications
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Obesity and poor diet often go hand-in-hand, altering metabolic signaling and thereby impacting breast cancer risk and outcomes. We have recently demonstrated that dietary patterns modulate mammary microbiota populations. An important and largely open question is whether the microbiome of the gut and mammary gland mediates the dietary effects on breast cancer. To address this, we performed fecal transplants between mice on control or high-fat diets (HFD) and recorded mammary tumor outcomes in a chemical carcinogenesis model. HFD induced protumorigenic effects, which could be mimicked in animals fed a control diet by transplanting HFD-derived microbiota. Fecal transplants altered both the gut and mammary tumor microbiota populations, suggesting a link between the gut and breast microbiomes. HFD increased serum levels of bacterial lipopolysaccharide (LPS), and control diet–derived fecal transplant reduced LPS bioavailability in HFD-fed animals. In vitro models of the normal breast epithelium showed that LPS disrupts tight junctions (TJ) and compromises epithelial permeability. In mice, HFD or fecal transplant from animals on HFD reduced expression of TJ-associated genes in the gut and mammary gland. Furthermore, infecting breast cancer cells with an HFD-derived microbiome increased proliferation, implicating tumor-associated bacteria in cancer signaling. In a double-blind placebo-controlled clinical trial of patients with breast cancer administered fish oil supplements before primary tumor resection, dietary intervention modulated the microbiota in tumors and normal breast tissue. This study demonstrates a link between the gut and breast that mediates the effect of diet on cancer.Significance:This study demonstrates that diet shifts the microbiome in the gut and the breast tumor microenvironment to affect tumorigenesis, and oral dietary interventions can modulate the tumor microbiota in patients with breast cancer.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Obesity and poor diet often go hand-in-hand, altering metabolic signaling and thereby impacting breast cancer risk and outcomes. We have recently demonstrated that dietary patterns modulate mammary microbiota populations. An important and largely open question is whether the microbiome of the gut and mammary gland mediates the dietary effects on breast cancer. To address this, we performed fecal transplants between mice on control or high-fat diets (HFD) and recorded mammary tumor outcomes in a chemical carcinogenesis model. HFD induced protumorigenic effects, which could be mimicked in animals fed a control diet by transplanting HFD-derived microbiota. Fecal transplants altered both the gut and mammary tumor microbiota populations, suggesting a link between the gut and breast microbiomes. HFD increased serum levels of bacterial lipopolysaccharide (LPS), and control diet–derived fecal transplant reduced LPS bioavailability in HFD-fed animals. In vitro models of the normal breast epithelium showed that LPS disrupts tight junctions (TJ) and compromises epithelial permeability. In mice, HFD or fecal transplant from animals on HFD reduced expression of TJ-associated genes in the gut and mammary gland. Furthermore, infecting breast cancer cells with an HFD-derived microbiome increased proliferation, implicating tumor-associated bacteria in cancer signaling. In a double-blind placebo-controlled clinical trial of patients with breast cancer administered fish oil supplements before primary tumor resection, dietary intervention modulated the microbiota in tumors and normal breast tissue. This study demonstrates a link between the gut and breast that mediates the effect of diet on cancer.Significance:This study demonstrates that diet shifts the microbiome in the gut and the breast tumor microenvironment to affect tumorigenesis, and oral dietary interventions can modulate the tumor microbiota in patients with breast cancer.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S1 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
BALB/c DMBA tumors were stained against Ki67 (A) and F4/80 (B) to determine effects of diet and microbiota on primary tumor proliferation and tumor-associated macrophage populations.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
BALB/c DMBA tumors were stained against Ki67 (A) and F4/80 (B) to determine effects of diet and microbiota on primary tumor proliferation and tumor-associated macrophage populations.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Length of duration of fish oil intervention potentiates microbial shift. A. Time (in days) breast cancer patients were taking oral fish oil or placebo supplements. Short-term administration is classified as less than or equal to 14 days (n=5) and long-term administration is classified as greater than or equal to 17 days (n=8) of intervention. B. Patient BMI by group display no difference in BMI by intervention or length of intervention groups. C. Relative proportional abundance of tumor and tumor-adjacent mammary gland microbiome by group. Each bar represents a subject and each colored box a bacterial taxon. The height of a color box represents the relative abundance of that organism within the sample. 'Other' represents lower abundance taxa. D. Taxonomic profile of identified genera in breast tumor and tumor adjacent mammary gland tissue samples obtained from breast cancer patients taking oral fish oil supplements grouped by length of intervention.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Length of duration of fish oil intervention potentiates microbial shift. A. Time (in days) breast cancer patients were taking oral fish oil or placebo supplements. Short-term administration is classified as less than or equal to 14 days (n=5) and long-term administration is classified as greater than or equal to 17 days (n=8) of intervention. B. Patient BMI by group display no difference in BMI by intervention or length of intervention groups. C. Relative proportional abundance of tumor and tumor-adjacent mammary gland microbiome by group. Each bar represents a subject and each colored box a bacterial taxon. The height of a color box represents the relative abundance of that organism within the sample. 'Other' represents lower abundance taxa. D. Taxonomic profile of identified genera in breast tumor and tumor adjacent mammary gland tissue samples obtained from breast cancer patients taking oral fish oil supplements grouped by length of intervention.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Effect of PUFA on apical polarity in S1 acini. S1 cells cultured in 3D were treated following differentiation (days 8-12) with 10 μM of n-6 arachidonic acid (AA) or with vehicle (ethanol). (A) Representative confocal images of acini treated with vehicle or arachidonic acid (AA) and stained for ZO-1. DAPI was used to counterstained nuclei. Arrows point at nonpolarized ZO-1 and the dashed circle outlines the location of apical ZO-1. (B) Bar graph of the percentages of acini with apically polarized ZO-1 following treatments with vehicle or AA. **p < 0.01. Size bar, 5 μm
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Effect of PUFA on apical polarity in S1 acini. S1 cells cultured in 3D were treated following differentiation (days 8-12) with 10 μM of n-6 arachidonic acid (AA) or with vehicle (ethanol). (A) Representative confocal images of acini treated with vehicle or arachidonic acid (AA) and stained for ZO-1. DAPI was used to counterstained nuclei. Arrows point at nonpolarized ZO-1 and the dashed circle outlines the location of apical ZO-1. (B) Bar graph of the percentages of acini with apically polarized ZO-1 following treatments with vehicle or AA. **p < 0.01. Size bar, 5 μm
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
A. Uninfected 4T1 tumor volume from mice treated 1 x weekly control diet-derived fecal transplant. B. Uninfected 4T1 tumor volume from mice treated 1 x weekly lard diet-derived fecal transplant. C. Tumor volume over time of uninfected 4T1 cells mixed with control diet-derived fecal conditioned media infected RAW 264.7 (macrophage) cells. D. Tumor volume over time of uninfected 4T1 cells mixed with lard diet-derived fecal conditioned media infected RAW 264.7 (macrophage) cells. E. Tumor proliferation as determined by Ki67 immunoreactivity. F. Gram-positive bacteria content in 4T1 breast tumors. G. LPS positive bacteria content in 4T1 tumors. H. Infiltrating tumor-associated macrophage content in 4T1 tumors was determined by F4/80 immunoreactivity. n=5-6.*p<0.05
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
A. Uninfected 4T1 tumor volume from mice treated 1 x weekly control diet-derived fecal transplant. B. Uninfected 4T1 tumor volume from mice treated 1 x weekly lard diet-derived fecal transplant. C. Tumor volume over time of uninfected 4T1 cells mixed with control diet-derived fecal conditioned media infected RAW 264.7 (macrophage) cells. D. Tumor volume over time of uninfected 4T1 cells mixed with lard diet-derived fecal conditioned media infected RAW 264.7 (macrophage) cells. E. Tumor proliferation as determined by Ki67 immunoreactivity. F. Gram-positive bacteria content in 4T1 breast tumors. G. LPS positive bacteria content in 4T1 tumors. H. Infiltrating tumor-associated macrophage content in 4T1 tumors was determined by F4/80 immunoreactivity. n=5-6.*p<0.05
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Length of duration of fish oil intervention potentiates microbial shift. A. Time (in days) breast cancer patients were taking oral fish oil or placebo supplements. Short-term administration is classified as less than or equal to 14 days (n=5) and long-term administration is classified as greater than or equal to 17 days (n=8) of intervention. B. Patient BMI by group display no difference in BMI by intervention or length of intervention groups. C. Relative proportional abundance of tumor and tumor-adjacent mammary gland microbiome by group. Each bar represents a subject and each colored box a bacterial taxon. The height of a color box represents the relative abundance of that organism within the sample. 'Other' represents lower abundance taxa. D. Taxonomic profile of identified genera in breast tumor and tumor adjacent mammary gland tissue samples obtained from breast cancer patients taking oral fish oil supplements grouped by length of intervention.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Length of duration of fish oil intervention potentiates microbial shift. A. Time (in days) breast cancer patients were taking oral fish oil or placebo supplements. Short-term administration is classified as less than or equal to 14 days (n=5) and long-term administration is classified as greater than or equal to 17 days (n=8) of intervention. B. Patient BMI by group display no difference in BMI by intervention or length of intervention groups. C. Relative proportional abundance of tumor and tumor-adjacent mammary gland microbiome by group. Each bar represents a subject and each colored box a bacterial taxon. The height of a color box represents the relative abundance of that organism within the sample. 'Other' represents lower abundance taxa. D. Taxonomic profile of identified genera in breast tumor and tumor adjacent mammary gland tissue samples obtained from breast cancer patients taking oral fish oil supplements grouped by length of intervention.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
A. Uninfected 4T1 tumor volume from mice treated 1 x weekly control diet-derived fecal transplant. B. Uninfected 4T1 tumor volume from mice treated 1 x weekly lard diet-derived fecal transplant. C. Tumor volume over time of uninfected 4T1 cells mixed with control diet-derived fecal conditioned media infected RAW 264.7 (macrophage) cells. D. Tumor volume over time of uninfected 4T1 cells mixed with lard diet-derived fecal conditioned media infected RAW 264.7 (macrophage) cells. E. Tumor proliferation as determined by Ki67 immunoreactivity. F. Gram-positive bacteria content in 4T1 breast tumors. G. LPS positive bacteria content in 4T1 tumors. H. Infiltrating tumor-associated macrophage content in 4T1 tumors was determined by F4/80 immunoreactivity. n=5-6.*p<0.05
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
A. Uninfected 4T1 tumor volume from mice treated 1 x weekly control diet-derived fecal transplant. B. Uninfected 4T1 tumor volume from mice treated 1 x weekly lard diet-derived fecal transplant. C. Tumor volume over time of uninfected 4T1 cells mixed with control diet-derived fecal conditioned media infected RAW 264.7 (macrophage) cells. D. Tumor volume over time of uninfected 4T1 cells mixed with lard diet-derived fecal conditioned media infected RAW 264.7 (macrophage) cells. E. Tumor proliferation as determined by Ki67 immunoreactivity. F. Gram-positive bacteria content in 4T1 breast tumors. G. LPS positive bacteria content in 4T1 tumors. H. Infiltrating tumor-associated macrophage content in 4T1 tumors was determined by F4/80 immunoreactivity. n=5-6.*p<0.05
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Effect of PUFA on apical polarity in S1 acini. S1 cells cultured in 3D were treated following differentiation (days 8-12) with 10 μM of n-6 arachidonic acid (AA) or with vehicle (ethanol). (A) Representative confocal images of acini treated with vehicle or arachidonic acid (AA) and stained for ZO-1. DAPI was used to counterstained nuclei. Arrows point at nonpolarized ZO-1 and the dashed circle outlines the location of apical ZO-1. (B) Bar graph of the percentages of acini with apically polarized ZO-1 following treatments with vehicle or AA. **p < 0.01. Size bar, 5 μm
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Effect of PUFA on apical polarity in S1 acini. S1 cells cultured in 3D were treated following differentiation (days 8-12) with 10 μM of n-6 arachidonic acid (AA) or with vehicle (ethanol). (A) Representative confocal images of acini treated with vehicle or arachidonic acid (AA) and stained for ZO-1. DAPI was used to counterstained nuclei. Arrows point at nonpolarized ZO-1 and the dashed circle outlines the location of apical ZO-1. (B) Bar graph of the percentages of acini with apically polarized ZO-1 following treatments with vehicle or AA. **p < 0.01. Size bar, 5 μm
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S1 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
BALB/c DMBA tumors were stained against Ki67 (A) and F4/80 (B) to determine effects of diet and microbiota on primary tumor proliferation and tumor-associated macrophage populations.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
BALB/c DMBA tumors were stained against Ki67 (A) and F4/80 (B) to determine effects of diet and microbiota on primary tumor proliferation and tumor-associated macrophage populations.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Obesity and poor diet often go hand-in-hand, altering metabolic signaling and thereby impacting breast cancer risk and outcomes. We have recently demonstrated that dietary patterns modulate mammary microbiota populations. An important and largely open question is whether the microbiome of the gut and mammary gland mediates the dietary effects on breast cancer. To address this, we performed fecal transplants between mice on control or high-fat diets (HFD) and recorded mammary tumor outcomes in a chemical carcinogenesis model. HFD induced protumorigenic effects, which could be mimicked in animals fed a control diet by transplanting HFD-derived microbiota. Fecal transplants altered both the gut and mammary tumor microbiota populations, suggesting a link between the gut and breast microbiomes. HFD increased serum levels of bacterial lipopolysaccharide (LPS), and control diet–derived fecal transplant reduced LPS bioavailability in HFD-fed animals. In vitro models of the normal breast epithelium showed that LPS disrupts tight junctions (TJ) and compromises epithelial permeability. In mice, HFD or fecal transplant from animals on HFD reduced expression of TJ-associated genes in the gut and mammary gland. Furthermore, infecting breast cancer cells with an HFD-derived microbiome increased proliferation, implicating tumor-associated bacteria in cancer signaling. In a double-blind placebo-controlled clinical trial of patients with breast cancer administered fish oil supplements before primary tumor resection, dietary intervention modulated the microbiota in tumors and normal breast tissue. This study demonstrates a link between the gut and breast that mediates the effect of diet on cancer.Significance:This study demonstrates that diet shifts the microbiome in the gut and the breast tumor microenvironment to affect tumorigenesis, and oral dietary interventions can modulate the tumor microbiota in patients with breast cancer.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Obesity and poor diet often go hand-in-hand, altering metabolic signaling and thereby impacting breast cancer risk and outcomes. We have recently demonstrated that dietary patterns modulate mammary microbiota populations. An important and largely open question is whether the microbiome of the gut and mammary gland mediates the dietary effects on breast cancer. To address this, we performed fecal transplants between mice on control or high-fat diets (HFD) and recorded mammary tumor outcomes in a chemical carcinogenesis model. HFD induced protumorigenic effects, which could be mimicked in animals fed a control diet by transplanting HFD-derived microbiota. Fecal transplants altered both the gut and mammary tumor microbiota populations, suggesting a link between the gut and breast microbiomes. HFD increased serum levels of bacterial lipopolysaccharide (LPS), and control diet–derived fecal transplant reduced LPS bioavailability in HFD-fed animals. In vitro models of the normal breast epithelium showed that LPS disrupts tight junctions (TJ) and compromises epithelial permeability. In mice, HFD or fecal transplant from animals on HFD reduced expression of TJ-associated genes in the gut and mammary gland. Furthermore, infecting breast cancer cells with an HFD-derived microbiome increased proliferation, implicating tumor-associated bacteria in cancer signaling. In a double-blind placebo-controlled clinical trial of patients with breast cancer administered fish oil supplements before primary tumor resection, dietary intervention modulated the microbiota in tumors and normal breast tissue. This study demonstrates a link between the gut and breast that mediates the effect of diet on cancer.Significance:This study demonstrates that diet shifts the microbiome in the gut and the breast tumor microenvironment to affect tumorigenesis, and oral dietary interventions can modulate the tumor microbiota in patients with breast cancer.